Evidence map›Paper›PMID 36575539›Full record

ArticleStem cell research & therapy2022

Effect of glucose depletion and fructose administration during chondrogenic commitment in human bone marrow-derived stem cells.

Daniele Zuncheddu, Elena Della Bella, Dalila Petta, Cecilia Bärtschi, Sonja Häckel, Moritz C Deml, Martin J Stoddart, Sibylle Grad, Valentina Basoli

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. A two-membrane gateway for monocarboxylates couples host glycolysis tobioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Relevance of Sugar Transport across the Cell Membrane.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Daniele Zuncheddu *AO Research Institute Davos, 7270, Davos Platz, Switzerland.
Elena Della Bella *AO Research Institute Davos, 7270, Davos Platz, Switzerland.
Dalila PettaRegenerative Medicine Technologies Laboratory, Laboratories for Translational Research (LRT), Ente Ospedaliero Cantonale (EOC), 6500, Bellinzona, Switzerland.
Cecilia BärtschiAO Research Institute Davos, 7270, Davos Platz, Switzerland.
Sonja HäckelDepartment of Orthopaedic Surgery and Traumatology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
Moritz C DemlDepartment of Orthopaedic Surgery and Traumatology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
Martin J StoddartAO Research Institute Davos, 7270, Davos Platz, Switzerland.
Sibylle GradAO Research Institute Davos, 7270, Davos Platz, Switzerland.
Valentina BasoliAO Research Institute Davos, 7270, Davos Platz, Switzerland. valentina.basoli@aofoundation.org.ORCID 0000-0002-4703-7308
AO Foundation · CHUniversity of Bern · CHEnte Ospedaliero Cantonale · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBone marrow mesenchymal stromal cells (BMSCs) are promising for therapeutic use in cartilage repair, because of their capacity to differentiate into chondrocytes. Often, in vitro differentiation protocols employ the use of high amount of glucose, which does not reflect cartilage physiology. For this reason, we investigated how different concentrations of glucose can affect the chondrogenic differentiation of BMSCs in cell culture pellets. Additionally, we investigated how fructose could influence the chondrogenic differentiation in vitro.

methodsBMSC were isolated from six donors and cultured in DMEM containing glucose at either 25 mM (HG), 5.5 mM (LG) or 1 mM (LLG), and 1% non-essential amino acids, 1% ITS+, in the presence of 100 nM dexamethasone, 50 µg/ml ascorbic acid-2 phosphate and 10 ng/ml TGF-β1. To investigate the effect of different metabolic substrates, other groups were exposed to additional 25 mM fructose. The media were replaced every second day until day 21 when all the pellets were harvested for further analyses. Biochemical analysis for glycosaminoglycans into pellets and released in medium was performed using the DMMB method. Expression of GLUT3 and GLUT5 was assayed by qPCR and validated using FACS analysis and immunofluorescence in monolayer cultures. Chondrogenic differentiation was further confirmed by qPCR analysis of COL2A1, COL1A1, COL10A1, ACAN, RUNX2, SOX9, SP7, MMP13, and PPARG, normalized on RPLP0. Type 2 collagen expression was subsequently validated by immunofluorescence analysis.

resultsWe show for the first time the presence of fructose transporter GLUT5 in BMSC and its regulation during chondrogenic commitment. Additionally, decreasing glucose concentration during chondrogenesis dramatically decreased the yield of differentiation. However, the use of fructose alone or together with low glucose concentrations does not limit cell differentiation, but on the contrary it might help in maintaining a stable chondrogenic phenotype comparable with the standard culture conditions (high glucose).

conclusionThis study provides evidence that BMSC express GLUT5 and differentially regulate GLUT3 in the presence of glucose variation. This study gives a better comprehension of BMSCs sugar use during chondrogenesis.

Indexed as

Bone MarrowMesenchymal Stem CellsBone Marrow CellsCell DifferentiationCells, CulturedChondrocytesChondrogenesisFructoseGlucoseGlucose Transporter Type 3HumansFructoseGlucoseGlucose Transporter Type 3CartilageChondrogenesisDifferentiationFructoseGlucoseHuman mesenchymal stem cells

Identifiers

PMID36575539
PMCPMC9795608
OpenAlexW4313249712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.